- Fund Type: ETF
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: International
SPDR S&P International Health Care Sector ETF
+ Add to WatchlistIRY:US
41.4000 USD 0.0200 0.05%As of 20:04:03 ET on 05/17/2013.
Snapshot for SPDR S&P International Health Care Sector ETF (IRY)
| Open: | 41.1200 | High - Low: | 41.4000 - 41.0388 | Primary Exchange: | NYSE Arca |
|---|---|---|---|---|---|
| Volume: | 21,352 | 52-Week Range: | 29.6300 - 41.9299 | Beta vs SPBMUHUP: | 0.8973 |
Fund Profile & Information for IRY
SPDR S&P International Health Care Sector ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to provide investment results that correspond generally to the total return performance of the S&P Developed Ex-U.S. BMI Health Care Sector Index.
| Inception Date: | 2008-07-16 | Telephone: | 1-866-787-2257 |
|---|---|---|---|
| Managers: | JOHN A TUCKER | ||
| Web Site: | www.spdrs.com | ||
Fundamentals for IRY
| NAV | (on 2013-05-17) 41.0829 |
|---|---|
| Assets (M) | (on 2013-05-17) 51.3536 |
| Shares out (M) | 1.25 |
| Market Cap (M) | 51.75 |
| % Premium | 0.77 |
| Average 52-Week % Premium | 0.2239 |
| Fund Leveraged | N |
Dividends for IRY
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | (on 2013-03-15) 0.2756 |
| Dividend Yield (ttm) | 1.91% |
Performance for IRY
| 1-Month | +3.99% | 1-Year | +36.47% |
|---|---|---|---|
| 3-Month | +10.69% | 3-Year | +18.44% |
| Year To Date | +16.43% | 5-Year | - |
| Expense Ratio | 0.50 |
Top Fund Holdings for IRY
Filing Date: 05/16/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Novartis AG | 80,419 | 6,052,277 | 11.678% |
| Roche Holding AG | 21,595 | 5,537,468 | 10.685% |
| Sanofi | 35,721 | 3,904,434 | 7.534% |
| GlaxoSmithKline PLC | 148,000 | 3,868,486 | 7.465% |
| Bayer AG | 24,572 | 2,691,521 | 5.193% |
| Novo Nordisk A/S | 12,983 | 2,245,664 | 4.333% |
| AstraZeneca PLC | 43,148 | 2,238,798 | 4.320% |
| Teva Pharmaceutical Industries | 39,817 | 1,587,509 | 3.063% |
| Takeda Pharmaceutical Co Ltd | 31,600 | 1,538,780 | 2.969% |
| CSL Ltd | 21,512 | 1,307,754 | 2.523% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page